Two subsets of peripheral blood plasma cells defined by differential expression of CD45 antigen

British Journal of Haematology

Volumn 97, Issue 1, 1997, Pages 56-64

  Schneider, Ulrike ^a   Van Lessen, Antje ^a   Huhn, Dieter ^a   Serke, Stefan ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

Author keywords

CD45 expression; flow cytometry; multiple myeloma; peripheral blood; plasma cells

Indexed keywords

CD45 ANTIGEN;

ARTICLE; CELL SUBPOPULATION; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MULTIPLE MYELOMA; PLASMA CELL; PRIORITY JOURNAL;

EID: 0030887392     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1997.d01-2115.x     Document Type: Article

References (34)

1. Bakkus, M.H.C., Van Riet, I., De Greef, C., Van Camp, B. & Thielemans, K. (1995) The clonogenic precursor cell in multiple myeloma. Leukemia and Lymphoma, 18, 221-229.
2. Barker, H.F., Ball, J., Drew, M. & Franklin, I.M. (1993) Multiple myeloma: the biology of malignant plasma cells. Blood Reviews, 7, 19-23.
3. Barker, H.F., Hamilton, M.S., Ball, J., Drew, M. & Franklin, I.M. (1992) Expression of adhesion molecules LFA-3 and N-CAM on normal and malignant human plasma cells. British Journal of Haematology, 81, 331-335.
4. Barlogie, B., Jagannath, S., Vesole, D. & Tricot, G. (1995) Autologous and allogenic transplants for multiple myeloma. Seminars in Hematology, 32, 31-44.
5. + peripheral blood cells expressing CD38, CD56 and monotypic Ig light chain. Blood, 85, 436-447.
6. Billadeau, D., Quam, L., Thomas, W., Kay, N., Greipp, P., Kyle, R., Oken, M.M. & Van Ness, B. (1992) Detection and quantitation of malignant cells in the peripheral blood of multiple myeloma patients. Blood, 80, 1818-1824.
7. Corradini, P., Voena, C., Omede, P., Astolfi, M., Boccadoro, M., Dalla-Favera, R. & Pileri, A. (1993) Detection of circulating tumor cells in multiple myeloma by a PCR-based method. Leukemia, 7, 1879-1882.
8. Dimopoulos, M.A., Hester, J., Huh, Y., Champlin, R. & Alexanian, R. (1994) Intensive chemotherapy with blood progenitor transplantation for primary resistant multiple myeloma. British Journal of Haematology, 87, 730-734.
9. Durie, B.G. & Salmon, S.E. (1975) A clinical staging system for multiple myeloma: correlation of measured myeloma cell mass with presenting clinical features, response to treatment and survival. Cancer, 36, 842-854.
10. Harada, H., Kawano, M.M., Huang, N., Harada, Y., Iwato, K., Tanabe, O., Tanaka, H., Sakai, A., Asaoku, H. & Kuramoto, K. (1993) Phenotypic difference of normal plasma cells from mature myeloma cells. Blood, 81, 2658-2663.
11. Harada, Y., Kawano, M.M., Huang, N., Mahmoud, M.S. & Lisukov, I.A. (1996) Identification of early plasma cells in peripheral blood and their clinical significance. British Journal of Haematology, 92, 184-191.
12. Hata, H., Xiao, H., Petrucci, M.T., Woodiff, J., Chang, R. & Epstein, J. (1993) Interleukin-6 gene expression in multiple myeloma: a characteristic of immature tumor cells. Blood, 81, 3357-3364.
13. + monoclonal B-lineage cells in peripheral blood from myeloma patients as late stage B cells. Blood, 78, 711-719.
14. Joshua, D.E. (1994) Multiple myeloma: Why does the disease escape from plateau phase? British Journal of Haematology, 88, 667-671.
15. Kawano, M.M., Huang, N., Harada, H., Harada, Y., Sakai, A., Tanaka, H., Iwato, K. & Kuramoto, A. (1993) Identification of immature and mature myeloma cells in the bone marrow of human myelomas. Blood, 82, 564-570.
16. Kreissig, C., Kirsch, A. & Serke, S. (1994) Characterization and measurement of CD34-expressing hematopoietic cells. Journal of Hematotherapy, 3, 263-290.
17. Kurtin, P.J. & Pinkus, G.S. (1985) Leukocyte common antigen - a diagnostic discriminant between hematopoietic and non-hematopoietic neoplasms in paraffin sections using monoclonal antibodies: correlation with immunologic studies and ultrastructural localization. Human Pathology, 16, 353-365.
18. + cells to remove circulating tumor cells. Blood, 87, 1635-1634.
19. - is the common phenotype of myeloma cells. Annals of Hematology, 64, 132-139.
20. Mathew, P., Ahmann, G.J., Witzig, T.E., Roche, P.C., Kyle, R.A. & Greipp, P.R. (1995) Clinicopathological correlates of CD56 expression in multiple myeloma: a unique entity? British Journal of Haematology, 90, 459-461.
21. Omede, P., Boccadoro, M., Fusaro, A., Gallone, G. & Pileri, A. (1993) Multiple myeloma: 'early' plasma cell phenotype identifies patients with aggressive biological and clinical characteristics. British Journal of Haematology, 85, 504-513.
22. Omede, P., Boccadoro, M., Gallone, G., Frieri, R., Battaglio, S., Redoglia, V. & Pileri, A. (1990) Multiple myeloma: increased circulating lymphocytes carrying plasma cell-associated antigens as an indicator of poor survival. Blood, 76, 1375-1379.
23. Pellat-Deceunynck, C., Bataille, R., Robillard, N., Harousseau, J.L., Rapp, M.J., Juge-Morineau, N., Wijdenes, J. & Amiot, M. (1994) Expression of CD28 and CD40 in human myeloma cells: a comparative study with normal plasma cells. Blood, 84, 2597-2603.
24. San Miguel, J.F., Gonzalez, M., Gascon, A., Moro, M.J., Hernandez, J.M., Ortega, F., Jimenez, R., Guerras, L., Romero, M., Casanova, F., Sanz, M.A., Sanchez, J., Portero, J.A. & Orfao, A. (1991) Immunophenotypic heterogeneity of multiple myeloma: influence on the biology and clinical course of the disease. British Journal of Haematology, 77, 185-190.
25. + peripheral blood progenitor cells after high-dose chemotherapy for patients with advanced multiple myeloma. Blood, 86, 390-397.
26. Shimazaki, C., Fried, J., Perez, G.A., Scheinberg, D.A., Atzpodien, J., Wang, C.Y., Wisnewolski, R. & Clarkson, B.D. (1990) Immunophenotypic analysis of lymphocytes and myeloma cells in patients with multiple myeloma. Acta Haematologica, 83, 123-129.
27. Terstappen, L.W.M.M., Johnsen, S., Segers-Nolten, M.J. & Loken, M.R. (1990) Identification and characterization of plasma cells in normal human bone marrow by high-resolution flow cytometry. Blood, 76, 1739-1747.
28. Van Riet, I., De Waele, M., Remels, L., Lacor, P., Schols, R. & Van Camp, B. (1991) Expression of cytoadhesion molecules (CD56, CD54, CD18 and CD29) by myeloma plasma cells. British Journal of Haematology, 79, 421-427.
29. Van Zaanen, H.C.T., Vet, R.J.W.M., De Jong, C.M., Von dem Borne, A.E.G.K. & Van Oers, M.H.J. (1995) A simple and sensitive method for determining plasma cell isotype and monoclonality in bone marrow using flow cytometry. British Journal of Haematology, 91, 55-19.
30. Wijdenes, J., Vooijs, W.C., Clement, C., Post, J., Morard, F., Vita, N., Laurent, P., Sun, R.X., Klein, B. & Dore, J.M. (1996) A plasmocyte selective monoclonal antibody (B-B4) recognizes syndecan-1. British Journal of Haematology, 94, 318-323.
31. Witzig, T.E., Dhodapkar, M.V., Kyle, R.A. & Greipp, P.R. (1995) Quantitation of circulating peripheral blood plasma cells and their relationship to disease activity in patients with multiple myeloma. Cancer, 72, 108-113.
32. Witzig, T.E., Gertz, M.A., Lust, J.A., Kyle, R.A. & Greipp, P.R. (1995a) Serial studies of peripheral blood myeloma cells in patients with multiple myeloma: when is the optimal time for stem cell harvest? Leukemia and Lymphoma, 19, 417-422.
33. Witzig, T.E., Geritz, M.A., Pineda, A.A., Kyle, R.A. & Greipp, P.R. (1995b) Detection of monoclonal plasma cells in the peripheral blood stem cell harvests of patients with multiple myeloma. British Journal of Haematology, 89, 640-642.
34. Witzig, T.E., Kimlinger, T.K., Ahmann, G.J., Katzmann, J.A. & Greipp, P.R. (1996) Detection of myeloma cells in the peripheral blood by flow cytometry. Cytometry, 26, 113-120.